News | July 08, 2022
ALPLA acquires Polish packaging manufacturer APON
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Subscribe To Our Newsletter & Stay Updated
